Abstract
Introduction
To determine the 1-year and 3-year adherence rates with Positive Airway Pressure (PAP) therapy in patients with schizophrenia compared to matched controls.
Methods
A case–control retrospective analysis was performed in a Veterans Affairs hospital. All symptomatic patients with schizophrenia ever started on PAP therapy between 2007 and 2015 were compared with controls matched for severity of sleep apnea based on AHI, BMI, and age at the time of diagnosis.
Results
Total number of subjects in both groups was 39. Mean AHI among cases and controls was 27.63 ± 22.16 and 33.59 ± 44.04 (p = 0.32), mean BMI was 34.91 ± 5.87 and 33.92 ± 5.21 (p = 0.43), and mean age at diagnosis was 53.6 ± 11.75 and 55.97 ± 11.92 (p = 0.36), respectively. There was no statistically significant difference in PAP use between patients with schizophrenia and controls at 1-year (percent days device use > 4 h—36.43% ± 31.41 vs. 49.09% ± 38.76; p = 0.17) and 3-year (percent days device use > 4 h—42.43 ± 35.50 vs. 60.53 ± 38.56; p = 0.089) visits
Conclusions
PAP adherence and usage is not significantly different among patients with schizophrenia compared to matched controls. Therefore, schizophrenia does not appear to influence CPAP compliance.
Similar content being viewed by others
References
Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR (2014) Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 10(4):355–362
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, Hamilton GS, Dharmage SC (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81
Kribbs NB, Pack AL, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147:887–895
World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63(10):892–909
MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, Chintoh A, Remington GJ, Taylor VH, Müeller DJ, Graff-Guerrero A, Hahn MK (2018) Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry 9:622
Myles H, Myles N, Antic NA, Adams R, Chandratilleke M, Liu D, Mercer J, Vakulin A, Vincent A, Wittert G, Galletly G (2016) Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophrenia Res 170:222–225
Sugishita K, Yamasue H, Kasai K (2010) Continuous positive airway pressure for obstructive sleep apnea improved negative symptoms in a patient with schizophrenia. Psychiatry Clin Neurosci 64:665
Boufidis S, Kosmidis MH, Bozikas VP, Daskalopoulou-Vlahoyianni E, Pitsavas S, Karavatos A (2003) Treatment outcome of obstructive sleep apnea syndrome in a patient with schizophrenia: case report. Int J Psychiatry Med 33(3):305–310
Grunstein PF, Fazleen A, Sankaran P (2017) Schizophrenia and obstructive sleep apnea: could CPAP cure both? Am J Respir Crit Care Med 195:A2597
Hiraoka T, Yamada N (2013) Treatment of psychiatric symptoms in schizophrenia spectrum disorders with comorbid sleep apnea syndrome: a case report. Seishin Shinkeigaku Zasshi 115(2):139–146 (in Japanese)
Owen-Smith A, Stewart C, Green C, Ahmedani BK, Waitzfelder BE, Rossom R, Copeland LA, Simon GE (2016) Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry 38:9–14
Nelson LA, Graham MR, Lindesy CC, Rasu RS (2011) Adherence to antihyperlipidemic medication and lipid control in diabetic veterans affairs patients with psychotic disorders. Psychomatics 52:310–318
Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Igancio RV, Valenstein M (2010) Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophrenia Bull 36(2):428–435
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Saoud, M., Saeed, M., Patel, S. et al. Positive Airway Pressure Adherence in Patients with Obstructive Sleep Apnea with Schizophrenia. Lung 198, 181–185 (2020). https://doi.org/10.1007/s00408-019-00302-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-019-00302-8